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Role of chemical composition and redox
modification of poorly soluble
nanomaterials on their ability to enhance
allergic airway sensitisation in mice
Susan Dekkers1* , James G. Wagner2, Rob J. Vandebriel1, Elyse A. Eldridge2, Selina V. Y. Tang3, Mark R. Miller4,
Isabella Römer5, Wim H. de Jong1, Jack R. Harkema2 and Flemming R. Cassee1,6
Abstract
Background: Engineered nanoparticles (NPs) have been shown to enhance allergic airways disease in mice.
However, the influence of the different physicochemical properties of these particles on their adjuvant properties is
largely unknown. Here we investigate the effects of chemical composition and redox activity of poorly soluble NPs
on their adjuvant potency in a mouse model of airway hypersensitivity.
Results: NPs of roughly similar sizes with different chemical composition and redox activity, including CeO2, Zr-doped
CeO2, Co3O4, Fe-doped Co3O4(using Fe2O3 or Fe3O4) and TiO2 NPs, all showed adjuvant activity. OVA induced immune
responses following intranasal exposure of BALB/c mice to 0.02% OVA in combination with 200 μg NPs during
sensitization (on day 1, 3, 6 and 8) and 0.5% OVA only during challenge (day 22, 23 and 24) were more pronounced
compared to the same OVA treatment regime without NPs. Changes in OVA-specific IgE and IgG1 plasma levels,
differential cell count and cytokines in bronchoalveolar lavage fluid (BALF), and histopathological detection of mucosa
cell metaplasia and eosinophil density in the conducting airways were observed. Adjuvant activity of the CeO2 NPs was
primarily mediated via the Th2 response, while that of the Co3O4 NPs was characterised by no or less marked increases
in IgE plasma levels, BALF IL-4 and IL-5 concentrations and percentages of eosinophils in BALF and more pronounced
increases in BALF IL-6 concentrations and percentages of lymphocytes in BALF. Co-exposure to Co3O4 NPs with OVA
and subsequent OVA challenge also induced perivascular and peribronchiolar lymphoid cell accumulation and
formation of ectopic lymphoid tissue in lungs. Responses to OVA combined with various NPs were not affected by the
amount of doping or redox activity of the NPs.
Conclusions: The findings indicate that chemical composition of NPs influences both the relative potency of NPs to
exacerbate allergic airway sensitization and the type of immune response. However, no relation between the acellular
redox activity and the observed adjuvant activity of the different NPs was found. Further research is needed to
pinpoint the precise physiological properties of NPs and biological mechanisms determining adjuvant activity in order
to facilitate a safe-by-design approach to NP development.
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Background
Engineered nanoparticles (NPs) are under increasing
development for a wide-range of applications, however,
their potential for toxicity still remains poorly under-
stood. Identifying which physicochemical properties of
NPs affect the potential toxicological effects will there-
fore facilitate predictive risk assessment, grouping and
safe-by-design of NPs [1–4].
The relative large surface-to-volume ratio and surface
reactivity of NPs are, for example, known to increase
reactive oxygen species (ROS) generation [5, 6]. As a
consequence, inhalation of NPs may lead to greater
levels of cellular oxidative stress and, subsequently in-
flammation in the respiratory system, than their larger
counterparts. In addition, existing inflammation (e.g.
from asthma) can also be exacerbated by NP exposure
[7, 8]. Nano-sized silica and titanium dioxide particles
have been shown to enhance allergic airways sensitisa-
tion in mice [9, 10], however, there is limited under-
standing of the different physicochemical properties of
NPs which influence their adjuvant properties. Previous
studies on the influence of NPs on allergic airway sensi-
tisation initially focussed on the role of the dendritic cell
and T-cell interaction. Increases in the proliferation,
maturation and/or differentiation of dendritic cells and
T-cells have been observed after in vitro exposure to
NPs and after in vivo exposure to NPs during the sensi-
tisation phase [7]. Molecular interactions that drive these
cellular responses have been suggested to involve in-
creases in reactive oxygen species (ROS) caused by NPs
with an oxidative surface chemistry, inflammasome acti-
vation, cellular injury and the induction of dendritic cell
simulating cytokines or chemokines by epithelial cells
(either direct or via oxidative stress) [7].
Nano-sized metal oxides are known to facilitate the
formation of ROS by depleting electrons from cellular
redox species (cellular components able to release elec-
trons) or by serving as catalysts in ROS production
through Fenton reactions or Haber-Weiss cycle reac-
tions [11]. Additionally, NPs can stimulate free radical
generation from cellular enzymes. Furthermore, bio-
logical fluids (e.g. epithelial lining fluid) and cells also
contain antioxidants and numerous compensatory
mechanisms, thus the relationship between ROS induc-
tion and toxicity is complex.
While there are clear associations between ROS gener-
ation and the toxicity of nanomaterials [11–13], the spe-
cific role of the redox activity of nanomaterials in the
generation of ROS is difficult to investigate, since chan-
ging the redox activity of nanomaterials usually also
changes other properties (such as the chemical compos-
ition or size). In a recent study, we applied chemical
doping (intentional substitution of one element by an-
other while maintaining the lattice structure and
arrangement) of cerium dioxide to specifically investigate
the influence of NP redox activity on ROS formation,
and associated induction of oxidative stress responses in
mice in vivo [14]. Different quantities of zirconium (Zr)
were incorporated into the crystalline structure of the
cerium dioxide nanoparticles (CeO2 NPs) to increase the
antioxidant potential. However, Zr-doping of CeO2 NPs
had limited effect on the inflammatory responses after
inhalation in otherwise healthy mice.
Metal oxides with a conduction band energy (Ec) level
that overlaps with the cellular redox potential (− 4.12
to − 4.84 eV) have been shown to have the ability to
induce oxygen radicals, oxidative stress, and acute pul-
monary inflammation [15]. Therefore, Co3O4, a metal
oxide that (unlike CeO2) has an Ec level overlapping with
the cellular redox potential was doped using Fe2O3 or
Fe3O4 (Fe oxides themselves do not overlap with the cellu-
lar redox potential). Here we present an airway exposure
study in a mouse model for airway allergy using the fol-
lowing poorly soluble NPs differing in redox potential but
with similar sizes: a) Co3O4 NPs doped with different
amounts of Fe, b) CeO2 NPs doped with different
amounts of Zr, c) CeO2 NM212 NPs (for comparison to
other in vivo studies) and d) TiO2 NPs (as a positive con-
trol [10]). We hypothesise that Co3O4 NPs will have a
greater ability to enhance allergic airway sensitisation
compared to (Zr-doped) CeO2 NPs, but that these effects
of Co3O4 NPs can be reduced by Fe-doping. The outcome
of this work will facilitate the assessment of the potential
hazard of NPs to enhance allergic airway sensitisation and
inform efforts to group NPs or to apply a safe-by-design
approach in their development.
Methods
Experimental protocol
Studies were designed to test the enhancement of allergic
sensitization by airway co-exposure (intranasal instillation)
of an experimental allergen (OVA) with a range of NPs
that differ in chemical composition (Fig. 1). Animals were
divided into 10 test groups and 3 control groups, each
with 6 mice except OVA-control (n = 8) (see Table 1). On
days 1, 3, 6 and 8 the mice were sensitized with 0.02%
OVA in combination with 200 μg TiO2 NPs (positive con-
trols), 0.02% OVA in combination with 200 µg of one of
the other NPs (test groups), 0.02% OVA in PBS (OVA
control) or PBS alone (PBS control). On days 22 and 23
all mice were challenged with 30 μl of 0.5% OVA in PBS.
The animals were sacrificed 24 h after the last intranasal
challenge (day 24).
A dose of 200 μg of NPs was chosen based on our re-
sults in previous studies (with dose-ranges between 100
and 400 μg) using silica [9] and titanium dioxide [10].
The mouse model was developed with low concentra-
tions of OVA during sensitization (0.02%) that produce
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minimal allergic responses with challenge, but can be
dramatically enhanced with co-sensitization with an ad-
juvant such as particulate matter [9].
No experimental groups were included to measure the
effects of exposure to NPs without OVA during the
sensitisation phase, since previous studies showed that
the allergic sensitisation response can only be enhanced
via co-exposure of the allergen and SiO2 or TiO2 NPs,
and not by exposure to SiO2 and TiO2 NP NPs alone
[9, 10]. Although other studies have shown that separ-
ate administration of the allergen and NPs may also
lead to adjuvant effects [16], in this study we have
chosen to administer OVA and NPs in one suspension,
in alignment with our previous studies.
Nanomaterial production and characterization
TiO2 NPs (NO-0058-HP) were obtained from Ionic Liq-
uids Technologies GmbH, Germany. These uncoated ana-
tase TiO2 NPs were the same NPs as used on our previous
in vivo study [10]. The OECD representative manufactured
nanomaterial CeO2 (NM212) was obtained from Umicore,
Belgium. The other CeO2 NPs, Zr-doped CeO2 NPs,
Co3O4 NPs and Fe-doped Co3O4 NPs were produced using
supercritical water hydrothermal synthesis [17, 18]. Briefly,
H2O was pumped through a pre-heating coil (~ 400 °C),
brought into contact with a concurrently flowing solution
of metal salts at room temperature (RT), while maintaining
the flow rates, temperature and the pressure constant at
240 bar. The mixture was cooled immediately after the mix-
ing point and passed through a back pressure regulator to
decrease the pressure back down to ambient conditions.
Solids in the aqueous suspensions were washed by centrifu-
ging and re-dispersing in clean MilliQ water 3 times. The
particles were characterised in suspension or, where solid
particles were required, the suspensions were oven dried
(~ 100 °C). For the synthesis of the Fe-doped Co3O4 NPs,
different ratios of cobalt and iron salts were used as precur-
sors. Two different iron salts (iron (III) nitrate nonahydrate
and ammonium iron (III) citrate) were used, resulting in
two different series of NPs, with Fe2O3 or Fe3O4 as a
precursor, respectively. These different series (Co3O4(x%
Fe2O3) NPs and Co3O4(x% Fe3O4) NPs) have different de-
grees of crystallinity, aggregation, Co/Fe ratio and spatial
distributions of the metals in the NPs [18].
The particle size in ultra-pure water was measured
with disc centrifuge. The particle size in cell culture
medium (RPMI 1640, Gibco) with 25 mM Hepes and 2
mML-Glutamine, 1% Penicilline-Streptomycine (Pen/
Strep 10,000 U/mL, Glibco) and 10% heat inactivated
Fetal Calf Serum (FCS, Glibco), was measured with dy-
namic light scattering (DLS). The redox activity was
tested with electron paramagnetic resonance (EPR) using
a cell free system with a superoxide-selective spin-trap
(tempone-H) to detect the generation of superoxide pro-
duction and the spin trap DMPO [19] in combination
with H2O2 and CuSO4 to analyse the capacity to scav-
enge hydroxyl free radicals. For the superoxide-selective
Fig. 1 Schematic overview of the study design
Table 1 Overview of the study groups
Group n Day 1, 3, 6 and 8 Day 22 and 23 Day 24
1 6 PBS controls OVA necropsy
2 8 OVA controls OVA necropsy
3 6 TiO2 + OVA (NP positive controls) OVA necropsy
4 6 CeO2 NM212 + OVA OVA necropsy
5 6 Co3O4(0% Fe2O3) + OVA OVA necropsy
6 6 Co3O4(25% Fe2O3) + OVA OVA necropsy
7 6 Co3O4(75% Fe2O3) + OVA OVA necropsy
8 6 Co3O4(0% Fe3O4) + OVA OVA necropsy
9 6 Co3O4(25% Fe3O4) + OVA OVA necropsy
10 6 Co3O4(75% Fe3O4) + OVA OVA necropsy
11 6 CeO2(0% Zr) + OVA OVA necropsy
12 6 CeO2(27% Zr) + OVA OVA necropsy
13 6 CeO2(78% Zr) + OVA OVA necropsy
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spin-trap nanoparticle suspensions (0.56 mg/mL) were
prepared and incubated with the spin-trap, Tempone-H
(1 mM) immediately before the initial measurement.
Samples were kept at 37 °C throughout and measure-
ments were taken with an X-band EPR spectrometer
(Magnettech MS-200, Berlin, Germany) at 60 min by
drawing 50 μL of sample into a capillary tube (Scientific
Laboratory Ltd., Coatbridge, UK) and sealing with a plug
of soft sealant (Cristaseal, VWR International, UK). For
the DMPO spin trap a sample was made of 12.5 μL
nanoparticle suspension (1.28 mg/mL), 12.5 μL CuSO4
(20 μM), 25 μL H2O2 (0.5M) and 50 μL DMPO (0.05M).
This sample was incubated in a shaker water bath at
37 °C for 15 min at 100 rpm, vortexed and taken up in a
capillary tube, which was then sealed at the bottom with
haematocrit and measured with the ESR Spectroscope
(Miniscope MS 400; MT MagnetTech GmbH). All NPs
were tested for endotoxin contamination using either a
Limulus Amoebocyte Lysate Assay (chromogenic kinetic
LAL assay) or LC-MS/MS determination [20].
Animals
Female BALB/c mice (~ 20 g body weight; 6–8 weeks
old) were obtained from Charles River (Portage, MI).
Mice were maintained at the Michigan State University
(MSU) animal housing facilities at room temperature
(21 °C–24 °C) and relative humidity of 45–70%, with a
12 h light/dark cycle. MSU is AAALAC accredited and
all animal procedures & experimental protocols were
approved by the MSU Institutional Animal Care and
Use Committee.
Intranasal instillation
Mice were lightly anesthetized for 1–2 min with 4% iso-
flurane in oxygen using an isoflurane vaporizer. Cradling
the mouse in an upright position, the thumb was used
to support the lower jaw and position the nose of the
mouse so it was easily accessible. A volume of 30 μL was
delivered to the tip of the nares. Once the instillate was
fully inhaled, the mouse was placed back in its cage and
monitored until conscious with normal respirations.
Necropsy, lavage collection and tissue preparation
Mice were anesthetized with an intraperitoneal injection
of sodium pentobarbital (60 mg/kg body weight). A
midline laparotomy was performed and approximately
0.5 mL of blood was drawn from the vena cava and col-
lected in heparinized tubes (BD Microtainer, Franklin
Lakes, NJ) for separation of plasma. The plasma was
stored at − 80 °C for later biochemical analysis (OVA-
specific IgE and IgG1). Animals were exsanguinated and
the trachea was exposed and cannulated, and the heart
and lungs were excised en bloc. A volume of 0.8 mL
sterile saline was instilled through the tracheal cannula
and withdrawn to recover bronchoalveolar lavage fluid
(BALF). A second intratracheal saline lavage was per-
formed and the collected BALF was combined with the
first sample for analysis.
After the BALF was collected, the left lung lobe was
intratracheally fixed with neutral-buffered formalin at a
constant pressure (30 cm H2O) for 2 h and then sub-
mersed in the same fixative for > 24 h until further tissue
processing for light microscopy. Two sections were ex-
cised at the level of the 5th and 11th airway along the
main axial airway (G5 and G11), to sample proximal and
distal bronchiolar airways, respectively [21]. Tissue was
embedded in paraffin and 5- to 6-μm-thick sections
were cut from the anterior surface. Lung sections were
stained with hematoxylin and eosin (H&E) for routine
light microscopic examination and with Alcian Blue
(pH 2.5)/Periodic Acid–Schiff (AB/PAS) for identifica-
tion of intraepithelial neutral and acidic mucosubstances
in pulmonary bronchiolar epithelium. To detect eosino-
phils, slides were immunostained using a polyclonal
rabbit antibody directed against murine eosinophil-
specific major basic protein (MBP; 1:500; Mayo Clinic,
AZ). Accumulations of B-lymphocytes in lung tissues
were detected by immunohistochemical staining with rat
anti-CD45R monoclonal (1:600; Becton Dickinson,
Franklin Lakes, NJ, catalog # 550286).
OVA-specific IgE and IgG1 in plasma
Plasma was separated from blood and analysed for
OVA-specific IgE and IgG1 using an ELISA kit (Cayman,
Ann Arbor, MI) according to the manufacturer’s instruc-
tions. The plasma samples were diluted 8 times for the
IgE and 1000 times for the IgG1 analysis.
BALF analyses
The total number of cells in the BALF was determined
using a hemocytometer. Cytological slides were prepared
by centrifugation at 40 x g for 10 min at 20 °C using a
Shandon cytospin 3 (Shandon Scientific, PA) and stained
with Diff-Quick (Dade Behring, DE). Differential cell
counts for neutrophils, eosinophils, macrophages/mono-
cytes, and lymphocytes were assessed from a total of at
least 200 cells. The remaining BALF was centrifuged at
240 x g for 15min at 4 °C and the supernatant was col-
lected and stored at − 80 °C for subsequent measurement
of inflammatory cytokines (IFNγ, IL-4, IL-5, IL-1β, IL-6, IL-
13, IL-17 and TNFα) using a Luminex-kit (Millipore, MA).
Lung morphometry
Histologic slides with lung tissue sections were scanned
and digitized with a slide scanner (VS110, Olympus
America, Center Valley, PA), and evaluated using stereo-
logical methods with newCAST software (VisioPharm,
Hoersholm, Denmark). For quantification of major basic
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protein (MBP)-positive eosinophils, digitized images of
the lung were selected as regions of interest and 40% of
the lung tissue was captured at 400x magnification by
systematic random sampling. Percentage of MBP-positive
cells in the total lung tissue and in three discrete regions
of 1) the parenchyma (alveoli and alveolar ducts), 2) peri-
vascular and peribronchial interstitial spaces, and 3) other
regions (inside blood vessels, bronchiole airspaces and
pleura), were estimated using Stepanizer stereology soft-
ware with a point grid by dividing the number of points
hitting areas positive for MPB (a(p)positive) by the total
number of points falling on all lung tissue (MBP-positive
and –negative; a(p)reference tissue). For each region, percent
density of eosinophils was calculated with the equation:
Eosinophil Density %ð Þ ¼ No:positive cellsð Þ  a pð Þpositive cell
No:reference tissueð Þ  a pð Þreference tissue
 100
For quantification of CD45R-positive staining cells
(the B-lymphocyte density), digitized images of G5 and
G11 lung sections were selected as regions of interest
and 40% of the lung tissue was captured at 400x magni-
fication by systematic random sampling. Percentage of
CD45R-positive cells in the perivascular and peribron-
chial interstitial spaces were estimated using Stepanizer
stereology software using a point grid by dividing the
number of points hitting areas positive for CD45R
(a(p)positive) by the total number of points falling on all
lung tissue (CD45R-positive and –negative; a(p)reference tissue).
For each region, percent density of B-lymphocytes was
calculated with the equation:
B−lymphocyte Density %ð Þ ¼ No:positive cellsð Þ  a pð Þpositive cell
No:reference tissueð Þ  a pð Þreference tissue
 100
For quantification of AB/PAS-positive mucosubstances
in the bronchiolar epithelium, all bronchiolar epithelium
lining the main axial airway was selected and captured at
400x magnification. A point intercept grid was placed
over the sampled images to estimate the density of
mucosubstances per basal lamina. The number of points
hitting AB/PAS-positive mucosubstances (Pm) was counted.
The density of AB/PAS-positive mucosubstances (V̂m) was
estimated by multiplying the total number of Pm by the
area/point (a/p) and dividing them by the number of points
hitting the reference space (n) as shown in the equation.
V^m ¼
P
Pm  a=p
n
The surface density of the basal lamina (ŜBL) in the
selected images was estimated by counting the number
of intercepts (I) of the line probe with the basal lamina
of the lateral wall divided by the length per point (l/p)
and the number of points falling on the reference space
(n) as described:
S^BL ¼ 2
P
I
l=p n
The positive density per basal lamina of the bronchiolar
epithelium was then estimated by dividing V̂m by ŜBL.
Statistical analyses
GraphPad Prism v7.00 (GraphPad Software, San Diego,
California, USA) was used to analyse the data. All data
are depicted as group means ± standard deviation (SD).
First, outliers were identified with Grubbs’ test (alpha =
0.05) and removed. The Shapiro-Wilk test and the Brown-
Forsythe test were used to test for normality and equal vari-
ances, respectively. Differences between the OVA control
group and a) the other control groups (PBS or TiO2 NP ex-
posed), b) the CeO2 NP exposed groups, c) the Co3O4(x%
Fe2O3) NP exposed groups and d) the Co3O4(x% Fe3O4)
NPs exposed groups were analysed using a one-way ana-
lysis of variance (ANOVA), followed by a Dunnett’s post-
hoc multiple comparisons test comparing groups exposed
to OVA with NPs to groups exposed to OVA alone. For all
statistical analyses, a p-value of ≤ 0.05 was considered sta-
tistically significant.
If the p-value of the Shapiro-Wilk or Brown-Forsythe
test was ≤ 0.05, the data were log-normally transformed
and again tested for normality and equal variances. If the
p-values of the Shapiro-Wilk and Brown-Forsythe tests
of the log-normally transformed data were > 0.05, a one-
way ANOVA followed by a Dunnett’s post-hoc multiple
comparisons test was performed on the log-normally
transformed data. If the p-values of the Shapiro-Wilk
test were still ≤ 0.05, a non-parametric (Kruskal Wallis)
ANOVA was performed on the non-transformed data
followed by a Dunn’s post-hoc multiple comparisons test.
Results
Nanomaterial characterization
Fe-doping had small, but not statistically significant,
effects on NP size in suspension (Table 2). Other charac-
teristics, such as shape and crystalline structure, did not
significantly change with increasing amounts of doping.
In Fig. 2, the redox activity of the NPs as measured in a
cell free system by EPR using two different spin-traps
are shown. EPR analysis using tempone-H demonstrated
an increased capacity of Co3O4(25% Fe3O4) NPs to
generate reactive superoxide free radicals compared to
Co3O4(0 and 75% Fe3O4) NPs. Increasing amounts of
Fe-doping using Fe3O4 led a significant decrease in scav-
enging capacity of Co3O4 NPs. Co3O4(0, 25 and 75%
Fe2O3) NPs had a similar ROS generation and scaven-
ging capacity (Fig. 2). Endotoxin levels were below the
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recommended endotoxin limits for preclinical research
in animal models (5 EU/kg bw/day or 36 EU/mL for
mice with a body weight of 30 g and a daily dose of
100 μL) [22].
OVA-specific IgE and IgG1 in plasma
OVA-specific IgE and IgG1 antibodies in plasma, indi-
cating an OVA-specific immune response, were
measured using an ELISA kit. OVA sensitization (0.02%
OVA) and challenge (0.5% OVA) caused minimal, non-
significant increases in plasma OVA-specific IgE and
IgG1 compared to non-sensitized mice (phosphate-buff-
ered saline (PBS) treated controls). Co-sensitization with
NPs further increased the plasma OVA-specific IgE or
IgG1 concentrations for all NPs. For all NPs, except for
Co3O4(0 and 75% Fe3O4) NPs, the OVA-specific IgE
Table 2 Physicochemical characteristics of the nanoparticles
Primary particle size
(Mean ± SD) (nm)
Particle diameter in water
(Median) (nm)
Particle diameter in cell culture
medium + 10% foetal calf serum
(Mean ± SD) (arbitrary units)
Measured with→ STEM Disc Centrifuge (128 μg/mL) DLS (128 μg/mL)
Anatase TiO2 10-15
a 121b –
CeO2 NM212 17.1 ± 10.9 – 428 ± 11.7
CeO2(0% Zr) 4.7 ± 1.4 39 288 ± 4.8
CeO2(27% Zr) 4.6 ± 1.4 40 176 ± 4.0
CeO2(78% Zr) 4.7 ± 1.4 41 415 ± 27.6
Co3O4(0% Fe2O3) 17.5 ± 15.0 42 176 ± 2.9
Co3O4(25% Fe2O3) 10.6 ± 3.6 62 303 ± 6.7
Co3O4(75% Fe2O3) 8.6 ± 1.7 39 373 ± 9.9
Co3O4(0% Fe3O4) 18.7 ± 11.2 44 160 ± 1.3
Co3O4(25% Fe3O4) 13.0 ± 5.2 61 828 ± 3.8
Co3O4(75% Fe3O4) 10.2 ± 6.2 69 1165 ± 66.5
aInformation provided by the manufacturer instead of measured with STEM; b Particles size as measured in our previous study with Nanoparticle Tracking Analysis
instead of Disc Centrifuge; SD Standard Deviation, STEM Scanning Transmission Electron Microscopy, DLS Dynamic Light Scattering, – = no data available
Fig. 2 Reactive oxygen species (ROS) generation and scavenging capacity of NPs. Superoxide generation of NPs measured in a cell free system
by electron paramagnetic resonance (EPR) using Tempone-H (a). The EPR signal of the Co3O4(25% Fe3O4) NPs was statistically significantly higher
than the Co3O4(0% Fe3O4) NPs (n = 4) indicating a larger capacity to generate ROS. Scavenging capacity of several NPs expressed as the
percentage reduction of the EPR signal of CuSO4 and NPs compared to CuSO4 alone, using a cell free system with a 5,5-dimethyl-1-pyrroline N-
oxide (DMPO) spin trap in combination with H2O2 (b). The percentage reduction of the CuSO4 signal by the Co3O4(75% Fe3O4) NPs was
significantly lower than that of the Co3O4(0 and 25% Fe3O4) NPs (n = 3), indicating a lower scavenging capacity of ROS
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and/or the IgG1 concentration was statistically signifi-
cantly increased compared to OVA alone (Fig. 3).
BALF analyses
BALF total cell count
The total and differential cell counts were determined
using a hemocytometer and analysis of cytospin prepared
slides. All mice sensitized with NP plus OVA showed a
significant increase in total BALF cells compared to the
OVA controls, indicating an increased inflammatory re-
sponse, except for animals exposed to Co3O4(0% Fe2O3)
NPs (p = 0.18; see Fig. 4a). For CeO2 NPs the total cell
count increased with increasing amounts of Zr doping.
Neutrophils
An increase in neutrophils in the BALF is indicative for
a non-allergic, acute inflammatory response. No statisti-
cally significant differences between the percentage of
neutrophils of the OVA controls and that of OVA plus
NP exposed animals were observed, except for a decreased
percentage of neutrophils in mice exposed to OVA plus
CeO2(78% Zr) NPs, Co3O4(25 and 75% Fe2O3) NPs and
Co3O4(75% Fe3O4) NPs. No major differences were ob-
served between the different types of NPs (see Fig. 4b).
The percentage of neutrophils decreased with the amount
of doping for Zr-doped CeO2 NPs and Fe-doped Co3O4
NPs (using both Fe2O3 and Fe3O4).
Eosinophils and lymphocytes
The animals exposed to OVA plus CeO2 NPs showed a
statistically significant increase in the percentage of eo-
sinophils compared to the OVA controls (Fig. 4c), which
is a typical feature of allergic asthma. For CeO2(27 and
78% Zr) NPs there was also a statistically significant
increase in the percentage of lymphocytes (Fig. 4d), indi-
cative for a chronic inflammatory response. Fe-doped
Co3O4 NPs (using both Fe2O3 and Fe3O4) caused a
statistically significant increase in the percentage of lym-
phocytes only, and not of eosinophils.
Monocytes
No major differences in the percentage of monocytes
were observed between mice sensitized with NP plus
OVA compared to the OVA controls (data not shown).
More detailed data, including the absolute differential
cell counts, can be found in Additional file 1.
BALF cytokines
The concentrations of several inflammatory cytokines in
the BALF were determined in using a Luminex-kit spe-
cific for the various cytokines evaluated. Animals ex-
posed to OVA plus CeO2 NPs showed increased
concentrations of the Th2 cytokines IL-4 and IL-5 (but
not IL-6 or IL-13) in the BALF compared to the OVA
controls. Animals exposed to OVA plus most undoped
and Fe-doped Co3O4 NPs showed increased concentra-
tions of IL-6 compared to the OVA controls. All ani-
mals, including the controls (exposed to PBS, OVA and
OVA plus TiO2 NPs during sensitization) had detectable
concentrations of IL-13 (20–50 ng/mL) but these were
not significantly different from one another (see Fig. 5d).
The concentrations of the other cytokines (IFNγ, IL-
1β, IL-17 and TNFα) measured in BALF were either
below the limits of detection or showed no significant
changes in the OVA plus NP exposed groups compared
Fig. 3 Concentration of OVA-specific IgE and IgG1 in plasma. Mean ± SD, n = 6 except OVA controls where n = 8, * = statistically significant
different from OVA controls (p < 0.05)
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to the OVA controls. More detailed data can be found
in Additional file 2.
Lung morphology
Mucous cell metaplasia
For quantification of epithelial mucous, lung tissue sec-
tions were stained with Alcian Blue/Periodic Acid Schiff
(AB/PAS), a marker for neutral and acidic mucosub-
stances. Increased epithelial mucous production is a
characteristic feature of allergic airway disease,
Sensitization and challenge with OVA caused a signifi-
cant accumulation of intraepithelial mucosubstances (mu-
cous cell metaplasia) in the epithelium lining the main
proximal axial airways (G5), which was further enhanced
by co-administration of OVA with TiO2 NPs (positive
control). All CeO2 NPs enhanced mucosubstance
accumulation; this was statistically significant for CeO2
NM212 and CeO2 with 27%, but not 78%, Zr doping (see
Fig. 6).
By comparison, in the distal axial airways (G11), OVA
sensitization and challenge did not affect epithelial accu-
mulated mucosubstances. Co-sensitization with OVA plus
TiO2 (positive control), CeO2 NM212, CeO2(0, 27 and
78% Zr), Co3O4(25% Fe2O3) and Co3O4(25% Fe3O4) NPs
led to a statistically significant increase in mucosubstances
compared to the OVA controls.
Eosinophil density
For quantification of the eosinophil density, a biomarker
for an allergic airway response, lung tissue sections were
stained for murine major basic protein (MBP), a specific
marker for eosinophils.
Fig. 4 Differential cell counts in bronchoalveolar lavage fluid (BALF). Total cell count (a) and percentage of neutrophils (b), eosinophils (c) and
lymphocytes (d) in the BALF. Mean ± SD, n = 6 except OVA where n = 8, * = statistically significant different from OVA controls (p < 0.05)
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Parenchymal lung tissue OVA sensitization and chal-
lenge did not increase the overall eosinophil density in
the pulmonary parenchyma compared to non-sensitized
mice (PBS controls). Co-sensitization of OVA with TiO2
(positive control) and CeO2 NPs significantly increased
eosinophil density compared to OVA alone. This in-
crease was statistically significant in all these groups, ex-
cept for the OVA plus CeO2 NM212 NPs group. Co-
sensitization of OVA with undoped and doped Co3O4
NPs had no effect on eosinophil density (Fig. 7a).
Perivascular and peribronchial lung tissue OVA
sensitization and challenge did not significantly affect
the eosinophil density in the peribronchial and perivas-
cular region of the lung compared to non-sensitized
mice (PBS controls). Co-sensitization of OVA with
TiO2 (positive control), CeO2(0, 27 and 78% Zr) and
Co3O4(25 and 75% Fe3O4) NPs caused significant in-
creases in eosinophil density compared to OVA alone
(Fig. 7b).
Total lung OVA sensitization and challenge did not sig-
nificantly alter the overall pulmonary eosinophil density
compared to non-sensitized mice (PBS controls). Co-
sensitization of OVA with TiO2 NPs (positive control),
CeO2(0 and 78% Zr) and Co3O4(25 and 75% Fe3O4) NPs
caused significant increases in eosinophil density com-
pared to OVA alone (Fig. 7c).
B-lymphocytes density
For quantification of the B-lymphocytes density lung tis-
sue sections were stained for CD45R, a marker for B-
lymphocytes.
Fig. 5 Cytokines in bronchoalveolar lavage fluid (BALF). Concentration of IL-4 (a), IL-5 (b), IL-6 (c) and IL-13 (d), in the BALF. Mean ± SD, n = 6
except OVA where n = 8, * = statistically significant different from OVA controls (p < 0.05)
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Fig. 6 Mucous cell metaplasia. Quantification of the increase in intraepithelial mucosubstance in the epithelium lining the main proximal axial
airway (G5; left) and distal axial airway (G11; right) of the left lung lobe. Mean ± SD, n = 6 except OVA where n = 8, * = statistically significant
different from OVA controls (p < 0.05)
Fig. 7 Eosinophil density. Quantification of the eosinophil density in the parenchymal (a), perivascular and peribronchial (b), and total (c) lung
tissue. Mean ± SD, n = 6 except OVA where n = 8, * = statistically significant different from OVA controls (p < 0.05)
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Co-sensitization with OVA and Co3O4 NPs induced a
severe accumulation of B-lymphocytes (CD45+ cells) in
the perivascular/peribronchiolar interstitium, indicative
for a chronic inflammatory response. By comparison, ac-
cumulation of B-lymphocytes in lungs from OVA plus
CeO2 NP-sensitised mice was not as evident (Fig. 8).
Lung histopathology
Examples of histopathological findings in the scanned
and digitized histologic slides of the lung tissue sections
are shown in Figs. 9 and 10. No exposure related micro-
scopically observable lung lesions were found in the PBS
control group (Fig. 9a and b). All mice that were intra-
nasally sensitized and challenged with OVA (OVA con-
trols) had some degree of histopathology in the lung
that was characteristic of allergic airway disease. This
histopathology consisted of a mixed inflammatory cell
influx containing eosinophils, lymphoid cells (lympho-
cytes and plasma cells) and, to a lesser extent, neutro-
phils in the interstitial tissue surrounding blood vessels
and conducting airways (perivascular and peribronchio-
lar inflammation) (most conspicuous in G5, see Fig. 9c,
but also in G11). Associated with these inflammatory
lesions, there was mucous cell metaplasia of the airway
epithelium (appearance of mucous cells with AB/PAS-
stained mucosubstances) (see Fig. 9d).
Mice co-exposed to OVA and NPs had a mild to mod-
erate multifocal accumulation of particle-laden, hyper-
trophic macrophages in alveolar air spaces (most
conspicuous in centriacinar regions of the lung) and
more severe inflammatory or epithelial lung lesions
compared to mice exposed to OVA alone. Mice co-
exposed to OVA and TiO2, CeO2 NM212, or Zr-doped
CeO2 NPs had more severe lymphocytic and eosino-
philic inflammation as (see Fig. 9e) as well as more se-
vere mucous cell metaplasia (most conspicuous in G11,
see Fig. 9f) compared to the OVA-alone treated mice
(see Fig. 9c and d).
In contrast, OVA and Co3O4(with or without Fe-
doping) co-exposed mice did not have more severe eo-
sinophilic inflammation or mucous cell metaplasia as
compared to OVA-alone treated mice. Interestingly,
these OVA and Co3O4 co-exposed mice exhibited more
severe perivascular or peribronchiolar lymphoid cell ac-
cumulation compared to mice co-exposed to the other
NPs, organized in ectopic lymphoid-like structures (ELS,
see Fig. 10a, b and c). ELS are tertiary lymphoid organs,
associated for example with infections and autoimmune
diseases, that develop in areas of chronic inflammation
and are characterized by the formation of organized B-
and T-cell aggregates and germinal centres with follicu-
lar dendritic cell networks [23, 24]. These lung lesions
were also observed in mice co-exposed to OVA and
Co3O4 with Fe-doping (using both Fe2O3 and Fe3O4, see
Fig. 10d, e and f).
Discussion
All NPs investigated possessed adjuvant activity, leading
to changes in OVA-specific IgE and IgG1 plasma levels,
differential cell count and cytokines in BALF, and histo-
pathological detection of mucosa cell metaplasia and
Fig. 8 B-lymphocyte density. Quantification of the B-lymphocyte density in the perivascular and peribronchial lung tissue. Mean ± SD, n = 6
except OVA where n = 8, * = statistically significant different from OVA controls (p < 0.05)
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eosinophil density in the conducting airways. Co-
exposure of OVA and Co3O4 NPs also induced perivas-
cular and peribronchiolar lymphoid cell accumulation
and the formation of ELS in lungs.
Adjuvant activity
Although the increased OVA-specific IgE and IgG1
plasma levels of all OVA + NP exposed groups com-
pared to OVA controls were not statistically significant
for all NPs, they do indicate that NPs have the capacity
to enhance allergic sensitisation in mice. This is supported
by the increases in eosinophils, lymphocytes, IL-4, IL-5
and IL-6 in BALF after co-exposure of OVA and many
NPs compared to the OVA controls. In our previous
study, we found that SiO2 and TiO2 NP exposure alone
(without OVA) during the induction phase did not lead to
an increase in OVA-specific IgE and IgG1 plasma levels or
eosinophils in BALF after OVA challenge [9, 10]. These
findings suggest that the allergic response can only be
enhanced via co-exposure of the allergen and NPs, and
not by exposure to NPs alone. In the current study, all
NPs were only tested in combination with OVA, and the
Fig. 9 Examples of observed histopathological findings in lungs. Light photomicrographs of G11, small-diameter, distal axial airway from the
lungs of PBS-treated mice (a, b), OVA-treated mice (c, d) and OVA+TiO2 NP treated mice (e, f). Lung tissue sections for a, c and e were stained
for murine major basic protein, a specific marker for eosinophils (red chromogen-stained cells; arrow 1). Tissue sections b, d and f were stained
with Alcian Blue/Periodic Acid Schiff (AB/PAS) for neutral and acidic mucosubstances (dark magenta stain; arrow 2) in mucous cells of the airway
epithelium (e). aa: axial airway lumen; bv: blood vessel; a: alveolus; arrow 3:mononuclear cell infiltrate (mainly lymphoid); arrow 4: TiO2 NP-laden
alveolar macrophages
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results show that all NPs were able to act as adjuvant,
albeit to varying degrees.
The influence of the chemical composition
The differences in OVA-specific IgE and IgG1 plasma
levels of the animals co-sensitized to OVA and the dif-
ferent NPs indicate that the chemical composition of the
NPs influences their potency to exacerbate allergic air-
way sensitization. The relative adjuvant potencies of the
different NPs varied with the different biomarkers of ef-
fects (Fig. 11), indicating that the chemical composition
also influences the type of the allergic response.
Type of the immune responses
Animals co-exposed to OVA and undoped CeO2 NPs
showed higher OVA-specific IgE plasma levels compared
to animals co-exposed to OVA and the other undoped
NPs (TiO2 NPs, CeO2 NM212 NPs, and Co3O4 NPs), in-
dicative for a type 1 (immediate or IgE mediated) allergic
response. Additionally, indications for a Th2 type im-
mune response were observed, characterised by an in-
crease in the percentage of eosinophils and increased
concentrations of the Th2 cytokines IL-4 and IL-5 (but
not IL-13) in the BALF. Animals co-exposed to OVA
and the OECD representative manufactured nanomater-
ial CeO2 (NM212), also showed some indications of a
Th2 type response, albeit less marked than those ob-
served in animals co-exposed to OVA and CeO2(0% Zr)
NPs: plasma OVA-specific IgE levels, percentage of eo-
sinophils in BALF and BALF IL-4 concentrations were
much lower in animals co-exposed to OVA and CeO2
NM212 than in animals co-exposed to OVA and
CeO2(0% Zr) NPs. In contrast, concentrations of IL-5 in
BALF were similarly affected by both forms of CeO2.
These findings are in line with a previous in vivo
study in which CeO2 NPs induced increased antigen
specific IgE levels, eosinophils, Th2 cytokines and
Th2 chemokines when co-exposed with house dust
mite [25] and an in vitro study in which CeO2 NPs
exposure of human dendritic cells induced a Th2-
dominated cell profile [26].
Co-exposure to OVA and undoped Co3O4 NPs also
showed responses indicative of a type 1 allergic response,
albeit, the OVA-specific IgE plasma levels were lower
Fig. 10 Examples of observed ectopic lymphoid structures in lungs. Light photomicrographs of G5, principally large-diameter, proximal
axial airway from the lungs of OVA+Co3O4(0% Fe2O3) NP treated mice (a, b, c), and OVA+ Co3O4(25% Fe2O3) NP-treated mice (d, e, f).
Lung tissue sections for A and D were stained for murine major basic protein, a specific marker for eosinophils (red chromogen-stained
cells; arrow 1). Tissue sections B and E were stained with Alcian Blue/Periodic Acid Schiff (AB/PAS) for neutral and acidic mucosubstances
(dark magenta stain; arrow 2) in mucous cells of the airway epithelium. Tissue sections C and F were stained with hematoxylin and eosin
(H&E). arrow 3: ectopic lymphoid structures (ELS), arrow 4: Co3O4 NP-laden alveolar macrophages; aa: axial airway lumen; a: alveolus
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compared to co-exposure to OVA and the CeO2(0% Zr)
NPs. Furthermore, the response after co-exposure to
OVA and Co3O4 NPs was characterised by no or less
marked increases in in BALF IL-4 and IL-5 concentra-
tions and the percentage of eosinophils in BALF, but a
more pronounced increase in the BALF IL-6 concentra-
tion and the percentage of lymphocytes in BALF com-
pared to co-exposure to OVA and the CeO2(0% Zr)
NPs. This pattern of response is in line with a previous
in vivo study in C57Bl/6 mice in which subcutaneous
administration of Co3O4 NPs with OVA induced both
Th1 and Th2 type responses [27]. Several biomarkers,
including the OVA-specific IgG1 plasma levels and IL-6
concentrations in the BALF, were remarkably different
in animals co-exposed to OVA and the two different
types of undoped Co3O4 NPs, indicating that not only
chemical composition, but also other physicochemical
characteristics of the NPs are of influence to the allergic
response. Although, the production process of the two
undoped Co3O4 NPs was the same, they differed in the
degree of crystallinity, aggregation, Co/Fe ratio and
spatial distributions of the metals in the NPs [18].
The immune response after co-exposure to OVA and
TiO2 NPs was indicative for a Th2 immune response,
characterised by an increase in eosinophils, IL-4 and IL-
5 in BALF. Previous studies with TiO2 NPs have found
contradictory results regarding effects on immune re-
sponses. Schanen et al. [26] found that exposure of den-
dritic cells to TiO2 NPs led towards Th1-based responses,
while Vandebriel et al. [10] and de Haar et al. [28] observed
Th2 type immune responses in mice after co-exposure to
OVA plus TiO2 NPs. However, the contradictory result
may have been caused by differences in the physicochemi-
cal characteristics (e.g. sizes and/or crystallinity) of the
TiO2 NPs used in the studies by Schanen et al. [26] and de
Haar et al. [28], compared to the TiO2 NPs used in our
study, which were the same TiO2 NPs as Vandebriel et al.
[10]. Although this study adds weight to the steering of the
immune response towards a Th2 response by TiO2 NP co-
exposure with antigens, more studies which measure a wide
range of Th2 and Th1/Th17 associated biomarkers are
needed to gain more insight in the type of adjuvant activity
associated with by TiO2 NPs exposure.
Lung morphology and ectopic lymphoid-like structures
Animals co-exposed to OVA and TiO2, CeO2 NM212,
or CeO2(0% Zr) NPs had more severe mucous cell meta-
plasia (most conspicuous in G11, but also in G5), as well
as more severe eosinophilic inflammation, compared to
the OVA-alone treated mice. OVA and Co3O4 co-
exposed mice showed more severe perivascular and peri-
bronchiolar lymphoid cell accumulation, organized into
ELS. These findings were accompanied by an increase in
lymphocytes in BALF. In mice broncho-associated
lymphoid tissue (BALT) is usually absent, however, it
can be induced (inducible BALT or iBALT) by inflam-
matory processes and infections [29]. In humans, iBALT
formation can be observed in the lung in response to
various types of infectious and inflammatory states,
caused by infectious organisms, diesel exhaust, cigarette
smoke silica, and various autoimmune diseases [30, 31].
In previous studies lymphocyte foci or aggregates have
been observed in lungs of rats after intratracheal instilla-
tion of Co3O4 NPs [32], as well as in lungs of mice after
intranasal exposure to OVA [33], crystalline silica parti-
cles (1.5–2.0 μm) [34] and after inhalation of CdO NPs
[35]. However, the role of iBALT in the pathophysiology
of chronic allergic diseases, such as asthma, is poorly
Fig. 11 The influence of the chemical composition on the different biomarkers of effect. The shading indicates the lowest (light grey),
intermediate (medium grey) or highest (dark grey) response of an NP (relative to the OVA controls) for each of the biomarkers. The bar on the
right side shows for each row the value corresponding with the indicated (medium) grey shading.
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understood [30, 31]. Studies investigating whether or not
iBALT is involved in the development or progression of
allergy or asthma showed conflicting results and the
pathways that control the development and function of
iBALT are poorly understood.
The influence of redox modification by doping
The differences in immune responses observed between
the groups exposed to the same type of NPs, but dif-
ferent amounts of doping (Zr-doping for CeO2 NPs
and Fe-doping for Co3O4 NPs), indicate that redox
modification can influence the adjuvant activity of
NPs. However, the amount of doping did not always
show a clear trend in the response of the different
biomarkers of effects. Some biomarkers indicated that
the undoped NPs exhibit most adjuvant activity, while
other biomarkers indicated that either the NP with
the lowest amount of doping or the NPs with the
highest amount of doping exhibited most adjuvant ac-
tivity. Additionally, most biomarkers of effects neither
decreased nor increased with greater degrees of dop-
ing (see in Additional file 3).
This lack of trend between increasing amounts of
doping and the biomarkers of effects is also observed in
the EPR data, in which only the Co3O4(0, 25 and 75%
Fe3O4) NPs showed a decreasing scavenging capacity
with increasing amounts of doping (see Fig. 2). This de-
crease in free hydroxyl radical scavenging capacity was
unexpected based on the Ec levels of Co3O4 and Fe3O4.
We expected that doping using Fe3O4 would increase,
rather than decrease the ability of Co3O4 to scavenge
free hydroxyl radicals, because the Ec level of Co3O4
overlaps with the cellular redox potential, whereas that
of Fe3O4 does not. On the other hand, the superoxide
generation did increase with Fe-doping of Co3O4 NPs
using 25% Fe3O4, but this ROS generation was not fur-
ther increased with increasing amounts of Fe-doping. It
is possible that differences in particle size and aggrega-
tion counterbalanced any doping-related differences in
free radical generation or scavenging [11, 36], as the par-
ticle size in water as measured with disc centrifuge was
larger for the Co3O4(75% Fe3O4) NPs compared to
Co3O4(25% Fe3O4) NPs, although the difference in par-
ticle size between these two NPs was relatively small.
Nonetheless, we would still have expected more notable
differences in free radical generation from the surfaces
of the differently doped materials. Physicochemical char-
acterisation of the materials indicates successful incorp-
oration of the doping into the crystal structure of the
NP [18], thus at present we can only speculate as to the
reason for the limited effect of doping on free radical
generation.
Since, the amount of doping or band gap energy of the
NPs were not predictive for adjuvant activity or the ability
to generate or scavenge specific radical, we also investi-
gated if the ability of the NPs to generate or scavenge spe-
cific radicals was predictive for the adjuvant activity.
The superoxide generation as measured with the EPR
was not predictive for the adjuvant activity. Only a few
biomarkers of effects decreased with decreasing amounts
of superoxide generation and these biomarkers of effects
were different for each of the NP series (see arrows in
Fig. 12).
The scavenging capacity as measured with the EPR
was also not predictive for the adjuvant activity. Only a
few biomarkers of effects decreased with increasing
amounts of scavenging capacity and these biomarkers of
effects were different for each of the NP series (see ar-
rows in Fig. 13).
While EPR is a useful technique to predict the ability
of NPs to generate cellular oxidative stress, this acellular
approach provides only a facet of the redox reactivity of
NPs within cellular compartments. However, due to the
number of NPs under investigation, a comprehensive
comparison of redox activity in cellular assays was not
possible within the current study. Therefore, a possible
explanation for the lack of trend between the EPR
results and the adjuvant activity is that redox activity of
the NPs may change due to interaction with the physio-
logical environment, e.g. by corona formation, aggrega-
tion, elimination, redox reactions, etc. Interactions with
the physiological environment are known to influence
the reactivity, cellular uptake and toxicity of the NPs
[37–40]. Han et al. [41] found that co-exposure of OVA
and polyethylene glycol-conjugated (PEGylated) SiO2
NPs induced less severe airway inflammation compared
to non-coated SiO2 NPs. It was suggested that this was
due to an increased aggregation of the PEGylated SiO2
NPs in saline compared to the non-coated SiO2. How-
ever, the small differences in the (aggregated) particle
diameter of the NPs in water observed in our study (see
Table 2) would be very unlikely to significantly influence
adjuvant potency. Larger differences in the (aggregated)
particle diameter of the NPs were observed in a more
physiologically relevant environment (i.e. buffered cell
culture medium with proteins from fetal calf serum) (see
Table 2). However, no relation between these differences
in aggregated size and the adjuvant potencies of the dif-
ferent NPs found. Horie et al. [42] found differences in
OVA-specific IgE and IgG1 concentrations in the blood
of mice exposed to ZnO compared to SiO2-coated ZnO
NPs after subsequent exposure to OVA. The investiga-
tors suggested that these differences might be due to dif-
ferences in solubility and continuous Zn2+ release from
the NPs. Although the NPs in our study are expected to
be relatively insoluble, further evaluation of the possible
degradation and ion release under various physiological
conditions (e.g. in lysosomal fluid) are needed to rule
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out this possibility. Further research is needed to better
understand the mechanisms of the adjuvant activity of
NPs, including the influence of the NP properties and
NP interactions with their physiological environment, in-
cluding allergens (such as OVA), on the adjuvant
activity.
Conclusions
The chemical composition of NPs in this study influ-
enced both their relative potency to exacerbate allergic
airway sensitization to ovalbumin (OVA), and the type
of the immune response. The adjuvant activity of CeO2
NPs seems to be primarily mediated via a Th2-type im-
mune response, whereas the adjuvant activity of Co3O4
NPs was characterised by no or less marked increases in
OVA-specific IgE plasma levels, BALF IL-4 and IL-5
concentrations and percentages of eosinophils in BALF
and more pronounced increases in the BALF IL-6 con-
centrations and percentages of lymphocytes in BALF.
Co-exposure to OVA and Co3O4 NPs also induced
lymphoid cell accumulation and the formation of ectopic
lymphoid tissues in the lungs. No relation between the
Fig. 12 The influence of the ability of NPs to induce superoxide generation as measured in an acellular EPR assay on the different biomarkers of
effects. The shading indicates the lowest (light grey) to highest (dark grey) response of an NP (relative to each other) for each of the biomarkers.
The arrows indicate an increase (↗) or decrease (↘) with decreasing amount of superoxide generation. The bar on the right side shows for each
row the value corresponding with the indicated (medium) grey shading.
Fig. 13 The influence of the scavenging capacity of the NPs as measured in an acellular EPR assay on the different biomarkers of effects. The
shading indicates the lowest (light grey) to highest (dark grey) response of an NP (relative to each other) for each of the biomarkers. The arrows
indicate an increase (↗) or decrease (↘) with increasing scavenging capacity. The bar on the right side shows for each row the value
corresponding with the indicated (medium) grey shading.
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acellular redox potential and the observed adjuvant ac-
tivity of the different of NPs was found, suggesting that
acellular ROS assays may not be suitable to predict adju-
vant capacity. These findings highlight the complexity of
biological interplay between different NP species and the
need for additional data and methods to formulate sce-
narios that better predict the adjuvant activity of nano-
material families.
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